Recent work, however, by the Italian historian Sergio Luzzatto has suggested that Pio faked his stigmata with carbolic acid — a controversial claim that can be neither proved nor disproved.
ITK SYK caused lethal T-cell lymphomas and the cytoplasmic TEL SYK fusion induced an acute panmyelosis with myelofibrosis-type acute myeloid leukemia (AML) with up to 50% immature megakaryoblasts infiltrating bone marrow, spleen and liver, additional MPN features (myelofibrosis and granulocyte expansion) and MDS stigmata with megakaryocytic and erythroid dysplasia.
Sister Anne was a mostly illiterate German nun who, in 1812, when she was thirty-eight, began to manifest stigmata, starting with a circle of bleeding wounds around her head, followed by wounds on her hands and feet and the imprint of a cross on her chest.
3.In the presence of stigmata associated with a high risk of rebleeding (Forrest type Ia, Ib, IIa), endoscopic hemostasis should be performed (strong agreement).
1.In the presence of stigmata associated with a low risk of rebleeding (Forrest type IIc and III), endoscopic hemostasis should not be used (strong agreement).
2.In the presence of stigmata associated with a low risk of rebleeding (Forrest type IIc and III), PPI treatment at "standard" doses should be continued (strong agreement).
5.In the presence of stigmata associated with a high risk of rebleeding (Forrest type Ia, Ib, IIa, IIb), PPI treatment should be continued at "high" doses for 72 h (strong agreement).
In contrast, no data suggestan excess risk related to endoscopic therapy and a systematic review showed a low incidence of complications [ 52]. 5.In the presence of stigmata associated with a high risk of rebleeding (Forrest type Ia, Ib, IIa, IIb), PPI treatment should be continued at "high" doses for 72 h (strong agreement).
The natural history of ulcer disease shows a rebleeding rate of approximately 5% only in the case of Forrest type IIc or III (Table 4) [ 44]. 2.In the presence of stigmata associated with a low risk of rebleeding (Forrest type IIc and III), PPI treatment at "standard" doses should be continued (strong agreement).
Further to the results of earlier studies [ 17, 34] we demonstrate the association of insulin resistance with the clinical entity of the MetS and with the individual MetS stigmata among patients with PAD, a population of a particular clinical interest.
The patient was diagnosed with IPMN with high-risk stigmata, and distal pancreatectomy (DP) with preservation of the spleen, namely MSPP, was performed.
